Pantomylan (Pantoprazole Sodium Sesquihydrate)

Pantoprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This blockade prevents the final step of acid secretion, leading to a sustained increase in gastric pH and relief of acid‑related symptoms.

The appropriate dose of Pantomylan is determined by the prescribing healthcare professional based on the specific indication, patient characteristics and clinical response. Dosage regimens may vary, and patients should follow the prescriber’s instructions without altering the dose on their own.

Pantoprazole should be used in pregnancy or while breastfeeding only if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the individual situation and advise accordingly.

To request Pantomylan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantomylan (pantoprazole) shares the core mechanism of acid suppression with other PPIs such as omeprazole and esomeprazole. Differences may include pharmacokinetic profiles, drug‑interaction potential and specific regulatory approvals. Clinical choice often depends on physician preference, patient tolerance and individual drug‑interaction considerations.

Pantomylan tablets should be stored at room temperature, below 25 °C, in their original blister pack or container. Protect them from moisture, excessive heat and direct sunlight to maintain product stability throughout its shelf life.

Pantomylan is taken orally, usually with water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to ensure optimal absorption and effectiveness.

Serious but rare risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, low magnesium levels (hypomagnesemia) with prolonged use, liver enzyme elevations, pancreatitis and interstitial nephritis. Patients should seek immediate medical attention if they experience any concerning symptoms.

Pantomylan is contraindicated in patients with known hypersensitivity to pantoprazole or any component of the formulation. Caution is also advised for individuals with severe hepatic impairment, those on certain interacting medications, and patients for whom alternative acid‑reducing therapies are more appropriate.